News

 

 

Recently Opened Clinical Trials

Thomas Davis
Associate Professor
Cancer Control

VentiRX.
A randomized, double-blind, placebo-controlled study of chemotherapy plus cetuximab in combination with VTX-2337 in patients with recurrent or metastatic squamous cell carcinoma of the head and neck

Konstantin Dragnev
Professor
Cancer Mechanism

Peregrine Pharmaceuticals, Inc
SUNRISE: A Phase III, randomized, double-blind, placebo-controlled multicenter trial of bavituximab plus docetaxel versus docetaxel alone as second-line therapy in patients with Stage IIIb/IV non-squamous non-small-cell lung cancer

Ryan Halter
Assistant Professor
Cancer Imaging and Radiology

Department of Defense (DoD)
Magnetic resonance-based electrical property tomography (Mr-Ept) for prostate cancer grade imaging

Frederick Lansigan
Assistant Professor
Molecular Therapeutics

Internal Funding
Incidence and risk factors of cutaneous T-cell lymphoma in New England

James Rigas
Assistant Professor
Molecular Therapeutics

Hoffman LaRoche
A Phase II, multicenter, single-arm study of MPDL2380A in patients with PD-L1-positive locally advanced or metastatic non-small cell lung cancer

Gary Schwartz
Assistant Professor
Molecular Therapeutics

ECOG
A cohort study to evaluate genetic predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS)

Internal Funding
Presurgical treatment with letrozole in patients with early-stage breast cancer